Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anliang Xia

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Molecular Therapy. Nucleic Acids|December 14, 2020
circRASGRF2 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1224 spongeDi Wu, Anliang Xia, Tianlong Fan, et al.
Molecular Therapy. Nucleic Acids|April 26, 2024
Retraction Notice to: circRASGRF2 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1224 spongeDi Wu, Anliang Xia, Tianlong Fan, et al.
Frontiers in Immunology|August 6, 2019
T Cell Dysfunction in Cancer Immunity and ImmunotherapyAnliang Xia, Yan Zhang, Jiang Xu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
Non-coding RNAs in radiotherapy resistance: Roles and therapeutic implications in gastrointestinal cancerKaiyue Xu, Huimin Guo, Anliang Xia, et al.
Journal of Medical Genetics|July 13, 2018
Exosomes derived from exhausted CD8+ T cells impaired the anticancer function of normal CD8+ T cellsXiaochen Wang, Haiyuan Shen, Qifeng He, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 30, 2023
Protein profiles reveal MSH6/MSH2 as a potential biomarker for hepatocellular carcinoma with microvascular invasionShengqian Hong, Jialing Zhang, Shiqi Liu, et al.
Iliver|May 25, 2026
Heterogeneity of hepatic macrophages in MASLD/MASH: Lipid-associated programs, molecular mechanisms, spatial niches, and therapeutic implicationsKaipeng Hu, Siyuan Liu, Shuyan Sheng, et al.
Journal of Hepatology|June 8, 2019
TOX promotes the exhaustion of antitumor CD8<sup>+</sup> T cells by preventing PD1 degradation in hepatocellular carcinomaXiaochen Wang, Qifeng He, Haiyuan Shen, et al.
Cell Proliferation|May 14, 2025
RBM39 Promotes Base Excision Repair to Facilitate the Progression of HCC by Stabilising OGG1 mRNAHongda An, Anliang Xia, Siyuan Liu, et al.
Frontiers in Oncology|February 2, 2023
A pan-cancer analysis of the prognostic and immunological roles of matrix metalloprotease-1 (MMP1) in human tumorsShuai Mao, Anliang Xia, Xuewen Tao, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Molecular Therapy. Nucleic Acids|December 14, 2020
circRASGRF2 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1224 spongeDi Wu, Anliang Xia, Tianlong Fan, et al.
Molecular Therapy. Nucleic Acids|April 26, 2024
Retraction Notice to: circRASGRF2 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1224 spongeDi Wu, Anliang Xia, Tianlong Fan, et al.
Frontiers in Immunology|August 6, 2019
T Cell Dysfunction in Cancer Immunity and ImmunotherapyAnliang Xia, Yan Zhang, Jiang Xu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
Non-coding RNAs in radiotherapy resistance: Roles and therapeutic implications in gastrointestinal cancerKaiyue Xu, Huimin Guo, Anliang Xia, et al.
Journal of Medical Genetics|July 13, 2018
Exosomes derived from exhausted CD8+ T cells impaired the anticancer function of normal CD8+ T cellsXiaochen Wang, Haiyuan Shen, Qifeng He, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 30, 2023
Protein profiles reveal MSH6/MSH2 as a potential biomarker for hepatocellular carcinoma with microvascular invasionShengqian Hong, Jialing Zhang, Shiqi Liu, et al.
Iliver|May 25, 2026
Heterogeneity of hepatic macrophages in MASLD/MASH: Lipid-associated programs, molecular mechanisms, spatial niches, and therapeutic implicationsKaipeng Hu, Siyuan Liu, Shuyan Sheng, et al.
Journal of Hepatology|June 8, 2019
TOX promotes the exhaustion of antitumor CD8<sup>+</sup> T cells by preventing PD1 degradation in hepatocellular carcinomaXiaochen Wang, Qifeng He, Haiyuan Shen, et al.
Cell Proliferation|May 14, 2025
RBM39 Promotes Base Excision Repair to Facilitate the Progression of HCC by Stabilising OGG1 mRNAHongda An, Anliang Xia, Siyuan Liu, et al.
Frontiers in Oncology|February 2, 2023
A pan-cancer analysis of the prognostic and immunological roles of matrix metalloprotease-1 (MMP1) in human tumorsShuai Mao, Anliang Xia, Xuewen Tao, et al.
Pageof 2